In December, Bowtie announced the launch of its Term Critical Illness (CI) Insurance product, the Bowtie Term CI Early Stage and Multiple Cover. The offering was rated as a top product by independent third-party insurance comparison platform 10Life shortly after it was launched, according to a press release.
The owner of the product, Mingo Tsang, explained the design concept and advantages of Bowtie’s latest offering in an interview. Tsang noted the driving force behind the market’s inclination towards CI insurance with saving components.
“Excluding commission factors, they indeed offer a broader coverage, providing multiple coverage, and coverage for early-stage critical illnesses,” said Tsang. “On the other hand, term critical illness insurance, lacking a savings component, offers relatively simple coverage.”
Drawing from research and analysis of over 40 critical illness insurance policies, Tsang identified three critical loopholes that could potentially jeopardize policyholders’ benefits:
Tsang conducted personal interviews with over 30 Bowtie customers to gauge their expectations and willingness to invest in enhanced coverage. The feedback underscored customers’ readiness to pay an additional premium of 10% to 15% for extended coverage. After gaining some enlightenment from user feedback, Bowtie’s development team worked on its new Early and Multiple Critical Illness Insurance. The product, released in December, includes the following coverage:
Tsang described Bowtie’s latest offering as “high-end protection at an affordable price for everyone.” A press release said the product is aligned with the company’s vision of “Just Fit protection”—the product strikes a balance between comprehensive coverage and affordability.
Bowtie is backed by Sun Life Financial, Mitsui & Co, and leading international investors. It offers products including voluntary health insurance scheme, life insurance, and CI insurance, among others.
Have something to say about this story? Leave a comment below.